Veterinary Oncology Market

Veterinary Oncology Market – By Cancer Diagnostics & Treatment (Diagnostics [Imaging, Biopsy], Treatment [Surgery, Chemotherapy]), Animal Type (Canine, Feline, Equine), Cancer Type (Mast Cell Tumors, Lymphomas, Melanoma) - Global Forecast, 2024 – 2032

Published Date: May - 2025 | Publisher: MIR | No of Pages: 240 | Industry: Animal Health and Nutrition | Format: Report available in PDF / Excel Format

View Details Buy Now 2890 Download Free Sample Ask for Discount Request Customization

Veterinary Oncology Market Size

Veterinary Oncology Market reached USD 923.5 million in 2023 and is expected to grow to USD 1.7 billion by 2032, with a growth of 7.1% during the 2024 – 2032 period. The market's growth can be ascribed to certain factors like growing pet ownership and awareness, high emphasis on early diagnosis and detection of cancer in animals, as well as improvements in diagnostic equipment.

To get key market trends

  Download Free Sample

In addition, rising spending on animal healthcare in developed countries, government programs for veterinary cancer therapy, and augmented adoption of pets are key drivers of market growth. As per information presented by the Canadian Animal Health Institute (CAHI) in September 2022, it was indicated that around 60% of Canadian households kept at least one dog or cat between 2020 and 2022. Therefore, with this huge number of animals present, it is expected that the rate of cancer among them will be higher, and thus it will contribute towards increasing the size of the market.

Veterinary Oncology Market Report Attributes
Report Attribute Details
Base Year 2023
Veterinary Oncology Market Size in 2023 USD 923.5 Million
Forecast Period 2024 - 2032
Forecast Period 2024 - 2032 CAGR 7.1%
2032 Value Projection USD 1.7 Billion
Historical Data for 2018 - 2023
No. of Pages 160
Tables, Charts & Figures 228
Segments covered Cancer Diagnostics & Treatment, Animal Type, Cancer Type, and Region
Growth Drivers
  • Rising prevalence and incidence of cancer in animals
  • Technological advancements in pet cancer diagnosis
  • Growing research and investments in pet cancer therapy
Pitfalls & Challenges
  • High cost of cancer treatment and procedures
  • Adverse effects of drugs used for pet cancer treatment

What are the growth opportunities in this market?

 Download Free Sample

Veterinary oncology is a branch of veterinary medicine that deals with cancer diagnosis, treatment, and prevention in animals. It entails the care of cancer in different animal species, such as dogs, cats, horses, and other pets.

Veterinary Oncology Market Trends

  • Cancer is the leading cause of death in pets after middle age. Consequently, due to the higher incidence of cancer in animals like dogs, demand for therapy is expected to increase in future years.
  • For example, based on a study conducted by Aging and Cancer in February 2022, it is estimated that 1 out of every 4 dogs develops cancer during their lifetime. Hence, with the increasing incidence of cancer among animals, there is expected to be a corresponding upsurge in demand for sophisticated and effective cancer therapeutics, leading to expected growth in the market.

However, high cost of cancer treatment and procedures and adverse effects of drugs may hamper the market growth to certain extent.

Veterinary Oncology Market Analysis

Learn more about the key segments shaping this market

 Download Free Sample

The market based on cancer diagnostics & treatment is segmented into diagnostics and treatment. The cancer treatment segment accounted for majority of market share of 56.2% in 2023.

  • Surgery is an important and very common mode of treatment in veterinary oncology. This involves the physical excision of tumors or cancerous tissue from the infested animal. The benefits of surgery in veterinary oncology are very significant and play a major role in cancer management in animals.
  • A main benefit of surgery is its ability to be locally curative. For tumors that are localized to one area or organ, removal of the tumor through surgery can be a cure, killing the cancerous cells and stopping them from spreading. This is especially true for solid tumors or masses that are well-defined and accessible.

Learn more about the key segments shaping this market

 Download Free Sample

Based on animal type, the veterinary oncology market is classified into canine, feline, equine, and other animal types. The canine segment is expected to hold 7.2% CAGR throughout the forecast period.

  • The segmental growth is attributable to the increasing high prevalence of cancer in canines, growing rate of pet adoption, and longer lifespans of these animals, all of which raise the probability of cancer. According to a Frontiers article published in March 2021, cancer stands as the primary cause of death in dogs.
  • This is predominantly attributed to the frequent diagnosis of cases at advanced stages, wherein the prognosis is less favourable and clinical symptoms have become apparent. Hence, due to this, the growing number of product approvals and launch of new therapeutics for canine cancer is anticipated to bolster the market expansion.

The veterinary oncology market based on cancer type is classified into mast cell tumors, mammary tumors, lymphomas, melanoma, and other cancer types. The lymphoma segment is expected to reach USD 487.3 million by 2032.

  • The evolution of therapeutic therapies for lymphoma, with the advent of novel chemotherapy drugs, immunomodulatory agents, and targeted therapy specifically suited for veterinary use, is set to usher in new treatment options and higher survival rates for animals with this disease. Consequently, the importance of comprehensive patient care and supportive service for dogs and cats diagnosed with lymphoma is increasing, including nutritional support, pain control, palliative care, and owner education.

Looking for region specific data?

 Download Free Sample

North America veterinary oncology market accounted for USD 400.8 million market revenue in 2023 and is anticipated to grow at CAGR of 6.9% between 2024 – 2032.

  • The increasing focus on pet care, availability of pet drug companies, and rapid adoption of advanced pet care products are some of the drivers that are expected to propel the growth of the regional market during the analysis period.
  • Additionally, the increasing government support for pet oncology treatment, the increase in pet insurance adoption, and the rapid growth of awareness related to in the oncology field, particularly for early diagnosis, play a key role in driving the regional market size.

Veterinary Oncology Market Share

The veterinary oncology industry is characterized by the presence of several key players offering innovative solutions. The strategic partnerships, mergers, and acquisitions are common strategies employed by players to expand their market presence, enhance their product portfolios, and gain a competitive advantage.

Veterinary Oncology Market Companies

Prominent players operating in the veterinary oncology industry include

  • AB Science
  • Accuray Incorporated
  • Boehringer Ingelheim International GmbH
  • Elanco
  • Karyopharm Therapeutics, Inc
  • NIPPON ZENYAKU KOGYO CO., LTD
  • PetCure Oncology
  • Regeneus Ltd
  • Varian Medical Systems, Inc
  • Virbac Corporation
  • Zoetis Services LLC

Veterinary Oncology Industry News

  • In July 2023, Ardent Animal Health and FidoCure agreed to partner and enhance the availability of oncology innovation in the veterinary medicine space. This partnership brings together Ardent's pipeline of cancer treatment technology with FidoCure's precision medicine platform and genomic testing capabilities to advance care for pets that have been diagnosed with cancer. Initiatives like these assist businesses in fortifying its product portfolio and market standing.
  • Elanco gained U.S. FDA approval in July 2021 for its TANOVEA as the first lymphoma treatment in dogs. The approval is a significant milestone in the field, equipping veterinarians with a new weapon to fight lymphoma, a prevalent canine cancer.

The veterinary oncology market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 – 2032 for the following segments

Click here to Buy Section of this Report

Market, By Cancer Diagnostics & Treatment

  • Diagnostics
    • By type
      • Imaging
      • Biopsy
      • Endoscopy
      • Other diagnostics
    • By end-use
      • Veterinary hospitals & clinics
      • Diagnostics centers
      • Other end-users
  • Treatment
    • By type
      • Surgery
      • Radiotherapy
      • Chemotherapy
      • Immunotherapy
      • Other treatments
    • By End-use
      • Veterinary hospitals
      • Veterinary clinics
      • Other end-users

Market, By Animal Type

  • Canine
  • Feline
  • Equine
  • Other animal types

Market, By Cancer Type

  • Mast cell tumors
  • Mammary tumors
  • Lymphomas
  • Melanoma
  • Other cancer types

The above information is provided for the following regions and countries

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • Rest of Middle East and Africa

 

Related Reports

Table of Content

  • Executive Summary
    1.1 Market Overview
    1.2 Key Findings
    1.3 Strategic Recommendations

  • Market Introduction
    2.1 Definition & Scope
    2.2 Research Methodology
    2.3 Assumptions & Limitations

  • Market Dynamics
    3.1 Drivers
    3.2 Restraints
    3.3 Opportunities
    3.4 Challenges
    3.5 Value Chain Analysis
    3.6 Porter’s Five Forces Analysis

  • Market Segmentation
    4.1 By Animal Type
        4.1.1 Dogs
        4.1.2 Cats
        4.1.3 Other Companion Animals
    4.2 By Therapy Type
        4.2.1 Chemotherapy
        4.2.2 Radiation Therapy
        4.2.3 Immunotherapy
        4.2.4 Targeted Therapy
    4.3 By Cancer Type
        4.3.1 Lymphoma
        4.3.2 Mast Cell Tumors
        4.3.3 Melanoma
        4.3.4 Mammary and Others
    4.4 By End-User
        4.4.1 Veterinary Clinics
        4.4.2 Animal Hospitals
        4.4.3 Research Institutes

  • Regional Analysis
    5.1 North America
    5.2 Europe
    5.3 Asia-Pacific
    5.4 Latin America
    5.5 Middle East & Africa

  • Competitive Landscape
    6.1 Market Share Analysis
    6.2 Company Profiles
        - Zoetis Inc.
        - Elanco Animal Health
        - Virbac
        - Boehringer Ingelheim Animal Health
        - Others

  • Recent Developments
    7.1 Mergers & Acquisitions
    7.2 Product Launches
    7.3 Collaborations & Partnerships

  • Future Outlook & Forecast (2025–2030)
    8.1 Market Size Projections
    8.2 Emerging Trends
    8.3 Strategic Opportunities

  • Appendix
    9.1 Glossary of Terms
    9.2 List of Abbreviations
    9.3 References
    9.4 Disclaimer

Will be Available in the sample /Final Report. Please ask our sales Team.

FAQ'S

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@marketinsightsresearch.com

Within 24 to 48 hrs.

You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email